Healthcare provider profile · identity verified

Jonathan Walton Walker, FNP

Nurse Practitioner · KING, NC · NPI 1508417114

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	288	71
Atorvastatin Calcium	Atorvastatin Calcium	271	82
Amlodipine Besylate	Amlodipine Besylate	262	82
Levothyroxine Sodium	Levothyroxine Sodium	229	74
Rosuvastatin Calcium	Rosuvastatin Calcium	221	68
Lisinopril	Lisinopril	214	64
Pantoprazole Sodium	Pantoprazole Sodium	211	67
Losartan Potassium	Losartan Potassium	205	75
Albuterol Sulfate Hfa	Albuterol Sulfate	189	55
Omeprazole	Omeprazole	189	56
Prednisone	Prednisone	172	137
Hydrochlorothiazide	Hydrochlorothiazide	157	51
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	145	35
Tamsulosin Hcl	Tamsulosin Hcl	145	46
Alprazolam	Alprazolam	136	44
Metoprolol Succinate	Metoprolol Succinate	135	46
Furosemide	Furosemide	130	44
Jardiance	Empagliflozin	128	15
Glipizide Er	Glipizide	107	31
Ozempic	Semaglutide	107	18
Pravastatin Sodium	Pravastatin Sodium	107	33
Simvastatin	Simvastatin	105	34
Zolpidem Tartrate	Zolpidem Tartrate	99	18
Montelukast Sodium	Montelukast Sodium	93	22
Allopurinol	Allopurinol	90	26
Carvedilol	Carvedilol	88	26
Sertraline Hcl	Sertraline Hcl	86	21
Quetiapine Fumarate	Quetiapine Fumarate	83	17
Duloxetine Hcl	Duloxetine Hcl	82	23
Fluticasone Propionate	Fluticasone Propionate	76	31
Tramadol Hcl	Tramadol Hcl	76	25
Eliquis	Apixaban	75	17
Hydroxyzine Hcl	Hydroxyzine Hcl	74	25
Metformin Hcl	Metformin Hcl	72	24
Escitalopram Oxalate	Escitalopram Oxalate	71	24
Baclofen	Baclofen	69	23
Pregabalin	Pregabalin	67	15
Metformin Hcl Er	Metformin Hcl	66	23
Trazodone Hcl	Trazodone Hcl	66	22
Farxiga	Dapagliflozin Propanediol	65	14
Metoprolol Tartrate	Metoprolol Tartrate	64	18
Glimepiride	Glimepiride	62	19
Methocarbamol	Methocarbamol	61	20
Clopidogrel	Clopidogrel Bisulfate	59	15
Diclofenac Sodium	Diclofenac Sodium	58	17
Doxycycline Hyclate	Doxycycline Hyclate	58	54
Potassium Chloride	Potassium Chloride	56	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	56	14
Lorazepam	Lorazepam	55	16
Ezetimibe	Ezetimibe	54	15
Meloxicam	Meloxicam	52	22
Clonazepam	Clonazepam	51	16
Spiriva Respimat	Tiotropium Bromide	49	suppressed
Famotidine	Famotidine	48	18
Mirtazapine	Mirtazapine	47	11
Azithromycin	Azithromycin	46	45
Fluoxetine Hcl	Fluoxetine Hcl	46	15
Breo Ellipta	Fluticasone/Vilanterol	45	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	42	40
Cefdinir	Cefdinir	42	37
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	42	25
Ondansetron Odt	Ondansetron	42	20
Oxycodone Hcl	Oxycodone Hcl	42	suppressed
Labetalol Hcl	Labetalol Hcl	41	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	41	32
Pioglitazone Hcl	Pioglitazone Hcl	39	15
Bupropion Xl	Bupropion Hcl	37	11
Finasteride	Finasteride	36	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	36	12
Rybelsus	Semaglutide	36	suppressed
Mounjaro	Tirzepatide	35	suppressed
Ropinirole Hcl	Ropinirole Hcl	35	12
Xarelto	Rivaroxaban	35	suppressed
Tizanidine Hcl	Tizanidine Hcl	33	12
Cephalexin	Cephalexin	32	30
Celecoxib	Celecoxib	31	12
Dicyclomine Hcl	Dicyclomine Hcl	31	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	31	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	suppressed
Ventolin Hfa	Albuterol Sulfate	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Nitroglycerin	Nitroglycerin	30	16
Warfarin Sodium	Warfarin Sodium	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Myrbetriq	Mirabegron	29	suppressed
Entresto	Sacubitril/Valsartan	27	suppressed
Trulicity	Dulaglutide	27	suppressed
Meclizine Hcl	Meclizine Hcl	26	14
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	25	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	25	suppressed
Spironolactone	Spironolactone	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Linzess	Linaclotide	23	suppressed
Tresiba Flextouch U-100	Insulin Degludec	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Topiramate	Topiramate	22	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	22	suppressed
Atenolol	Atenolol	21	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Olanzapine	Olanzapine	21	suppressed
Glipizide	Glipizide	20	suppressed
Novolog Flexpen	Insulin Aspart	20	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	19	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	19	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Ramipril	Ramipril	19	suppressed
Spiriva Handihaler	Tiotropium Bromide	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Mupirocin	Mupirocin	18	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	18	suppressed
Bumetanide	Bumetanide	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Fluconazole	Fluconazole	17	13
Rizatriptan	Rizatriptan Benzoate	17	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	17	suppressed
Diazepam	Diazepam	16	11
Dropsafe Prep Pads	Alcohol Antiseptic Pads	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Telmisartan	Telmisartan	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Ketoconazole	Ketoconazole	14	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Aimovig Autoinjector	Erenumab-Aooe	13	suppressed
Amoxicillin	Amoxicillin	13	11
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Liothyronine Sodium	Liothyronine Sodium	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Rexulti	Brexpiprazole	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Acetazolamide	Acetazolamide	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Belsomra	Suvorexant	12	suppressed
Estradiol	Estradiol	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	11
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Temazepam	Temazepam	12	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	11	suppressed
Oxycontin	Oxycodone Hcl	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Testosterone Cypionate	Testosterone Cypionate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error